Showing results (11-20 of 74) with videos related to
Sort By:
Pageof 8
Hybridoma|September 4, 1999
Use of monoclonal antibodies for the diagnosis and treatment of bladder cancerK N Syrigos, D P Deonarian, A A EpenetosCancer Treatment Reviews|July 23, 2013
Hormones of adipose tissue and their biologic role in lung cancerE Ntikoudi, M Kiagia, P Boura, et al.Annals of Surgical Oncology|December 29, 2000
The role of E-cadherin-catenin complex: more than an intercellular glue?K J Harrington, K N Syrigos, K J HaringtonGastroenterology Research and Practice|November 6, 2012
Desmoplasia in pancreatic cancer. Can we fight it?E E Merika, K N Syrigos, M W SaifAnticancer Research|March 26, 2002
Expression patterns of alpha-, beta- and gamma-catenin in pancreatic cancer: correlation with E-cadherin expression, pathological features and prognosisA J Karayiannakis, K N Syrigos, A Polychronidis, et al.Cancer Metastasis Reviews|January 29, 2008
Targeted therapy for oesophageal cancer: an overviewK N Syrigos, A Zalonis, E Kotteas, et al.Anticancer Research|August 10, 2002
Cytotoxic therapy of gastroenteropancreatic (GEP) tumorsK N Syrigos, D Sitara, E Georgiou, et al.The Journal of Urology|October 23, 1998
Altered gamma-catenin expression correlates with poor survival in patients with bladder cancerK N Syrigos, K Harrington, J Waxman, et al.European Journal of Cancer (Oxford, England : 1990)|March 10, 1999
Abnormal expression of p120 correlates with poor survival in patients with bladder cancerK N Syrigos, A Karayiannakis, E I Syrigou, et al.Acta Oncologica (Stockholm, Sweden)|June 25, 1999
Intravesical administration of radiolabelled tumour-associated monoclonal antibody in bladder cancerK N Syrigos, M Khawaja, T Krausz, et al.Pageof 8